Herantis Pharma (Finland) Probability of Future Stock Price Finishing Over 10.68
| HRTIS Stock | EUR 1.44 0.02 1.41% |
Herantis |
Herantis Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Herantis Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Herantis Pharma Oyj can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Herantis Pharma Oyj generated a negative expected return over the last 90 days | |
| Herantis Pharma Oyj may become a speculative penny stock | |
| Herantis Pharma Oyj has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (12.77 M) with profit before overhead, payroll, taxes, and interest of 90 K. | |
| Herantis Pharma Oyj has accumulated about 7.86 M in cash with (9.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.81. | |
| Roughly 32.0% of the company shares are held by company insiders |
Herantis Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Herantis Stock often depends not only on the future outlook of the current and potential Herantis Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Herantis Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 11.1 M |
Herantis Pharma Technical Analysis
Herantis Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Herantis Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Herantis Pharma Oyj. In general, you should focus on analyzing Herantis Stock price patterns and their correlations with different microeconomic environments and drivers.
Herantis Pharma Predictive Forecast Models
Herantis Pharma's time-series forecasting models is one of many Herantis Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Herantis Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Herantis Pharma Oyj
Checking the ongoing alerts about Herantis Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Herantis Pharma Oyj help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Herantis Pharma Oyj generated a negative expected return over the last 90 days | |
| Herantis Pharma Oyj may become a speculative penny stock | |
| Herantis Pharma Oyj has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (12.77 M) with profit before overhead, payroll, taxes, and interest of 90 K. | |
| Herantis Pharma Oyj has accumulated about 7.86 M in cash with (9.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.81. | |
| Roughly 32.0% of the company shares are held by company insiders |
Other Information on Investing in Herantis Stock
Herantis Pharma financial ratios help investors to determine whether Herantis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Herantis with respect to the benefits of owning Herantis Pharma security.